Mechanisms involved in reperfusion arrhythmias

Area of Science:

• Cardiology
• Pharmacology
• Electrophysiology

Background:

• Reperfusion following myocardial ischemia can trigger dangerous arrhythmias.
• Release of ischemic cellular products during reflow contributes to arrhythmogenesis.
• Calcium channel blockers offer a potential therapeutic strategy for managing these arrhythmias.

Purpose of the Study:

• To evaluate the antifibrillatory effects of various calcium channel blocking agents.
• To compare the efficacy of different agents during myocardial ischemia and reperfusion.
• To determine the influence of drug properties on antiarrhythmic activity.

Main Methods:

• Experimental studies in animal models.
• Assessment of ventricular fibrillation vulnerability during ischemia and reperfusion.
• Administration of various calcium channel blockers including verapamil, diltiazem, prenylamine, tiapamil, and nifedipine.

Main Results:

• Verapamil, diltiazem, and prenylamine demonstrated significant antifibrillatory effects during both ischemia and reperfusion.
• Tiapamil was effective during ischemia but not reperfusion.
• Nifedipine showed moderate efficacy during ischemia and was ineffective during reperfusion.

Conclusions:

• Calcium channel blockers vary significantly in their ability to suppress arrhythmias during myocardial ischemia and reperfusion.
• The effectiveness of these agents is critically dependent on the underlying pathophysiologic mechanisms and individual drug pharmacologic profiles.